These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy. Novoyatleva T; Janssen W; Wietelmann A; Schermuly RT; Engel FB Cytokine; 2013 Oct; 64(1):43-5. PubMed ID: 23764551 [TBL] [Abstract][Full Text] [Related]
24. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048 [TBL] [Abstract][Full Text] [Related]
25. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis. Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741 [TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB. Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679 [TBL] [Abstract][Full Text] [Related]
27. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617 [TBL] [Abstract][Full Text] [Related]
28. FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14. Novoyatleva T; Sajjad A; Pogoryelov D; Patra C; Schermuly RT; Engel FB FASEB J; 2014 Jun; 28(6):2492-503. PubMed ID: 24571920 [TBL] [Abstract][Full Text] [Related]
31. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis. Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957 [TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa). Shui Y; Guan ZB; Zhang SQ Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982 [TBL] [Abstract][Full Text] [Related]
33. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis. Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway. Ye Y; Hu SJ; Li L FEBS Lett; 2009 Sep; 583(18):2997-3003. PubMed ID: 19716825 [TBL] [Abstract][Full Text] [Related]
35. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes. Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway. Michaelson JS; Burkly LC Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634 [TBL] [Abstract][Full Text] [Related]
37. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin. Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836 [TBL] [Abstract][Full Text] [Related]
38. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition. Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197 [TBL] [Abstract][Full Text] [Related]
39. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes. Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961 [TBL] [Abstract][Full Text] [Related]
40. TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-кB pathway. Chen HN; Wang DJ; Ren MY; Wang QL; Sui SJ Mol Biol Rep; 2012 Aug; 39(8):8231-41. PubMed ID: 22555979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]